1. Home
  2. Product Labeler Index - B
  3. Company Labeler Name: Bamboo Us Bidco Llc

NDC Product Labeler Bamboo Us Bidco Llc

Bamboo Us Bidco Llc labeler's code is 83703. The labeler has 44 products that have an assigned National Drug Code.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Product Type Status
83703-044Fluzone Quadrivalent Northern Hemisphere Influenza A Virus A/victoria/2570/2019 Ivr-215 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/darwin/9/2021 San-010 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated)Injection, SuspensionIntramuscularVaccineACTIVE
83703-045Vaqta Hepatitis A Vaccine, InactivatedInjection, SuspensionIntramuscularVaccineACTIVE
83703-046Vaqta Hepatitis A Vaccine, InactivatedInjection, SuspensionIntramuscularVaccineACTIVE
83703-047Gardasil 9 Human Papillomavirus 9-valent Vaccine, RecombinantInjection, SuspensionIntramuscularVaccineACTIVE
83703-048Heplisav-b Hepatitis B Vaccine (recombinant) AdjuvantedInjection, SolutionIntramuscularVaccineACTIVE
83703-049Sterile Diluent For M-m-r Ii Measles, Mumps, And Rubella Virus Vaccine LiveInjection, Powder, Lyophilized, For SuspensionSubcutaneousVaccineACTIVE
83703-061Fluzone Trivalent Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/california/122/2022 San-022 (h3n2) Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated)Injection, SuspensionIntramuscularVaccineACTIVE
83703-062Flucelvax Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza A Virus A/sydney/1304/2022 (h3n2) Antigen (mdck Cell Derived, Propiolactone Inactivated), Influenza B Virus B/singapore/wuh4618/2021 Antigen (mdck Cell Derived, Propiolactone Inactivated)Injection, SuspensionIntramuscularVaccineACTIVE
83703-079Fluzone Quadrivalent Northern Hemisphere Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/california/122/2022 San-022 (h3n2) Antigen (formaldehyde Inactivated), Influenza B Virus B/phuket/3073/2013 Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated)Injection, SuspensionIntramuscularVaccineACTIVE
83703-080Fluzone Trivalent Southern Hemisphere Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated), Influenza A Virus A/croatia/10136rv/2023 X-425a (h3n2) Antigen (formaldehyde Inactivated), And Influenza B Virus B/michigan/01/2021 Antigen (formaldehyde Inactivated)Injection, SuspensionIntramuscularVaccineACTIVE
83703-549Cyclophosphamide CyclophosphamideInjection, Powder, For SolutionIntravenous; OralHuman Prescription DrugACTIVE
83703-550Cyclophosphamide CyclophosphamideInjection, Powder, For SolutionIntravenous; OralHuman Prescription DrugACTIVE
83703-551Cyclophosphamide CyclophosphamideInjection, Powder, For SolutionIntravenous; OralHuman Prescription DrugACTIVE
83703-559Mesnex MesnaInjection, SolutionIntravenousHuman Prescription DrugACTIVE
83703-037Flucelvax Quadrivalent
83703-038Hyqvia
83703-039Hyqvia
83703-040Hyqvia
83703-041Hyqvia
83703-042Hyqvia
83703-043M-m-r Ii
83703-001 Choriogonadotropin AlfaInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED
83703-511 ZolbetuximabInjectionDrug For Further ProcessingUNFINISHED
83703-516 ZolbetuximabInjectionDrug For Further ProcessingUNFINISHED
83703-530 Datopotamab DeruxtecanInjectionDrug For Further ProcessingUNFINISHED
83703-563 PaclitaxelInjection, Powder, Lyophilized, For SuspensionDrug For Further ProcessingUNFINISHED
83703-564 Brentuximab VedotinPowder, For SolutionDrug For Further ProcessingUNFINISHED
83703-567 BusulfanInjectionDrug For Further ProcessingUNFINISHED
83703-568 MecaserminInjection, SolutionDrug For Further ProcessingUNFINISHED
83703-569 MecaserminInjection, SolutionDrug For Further ProcessingUNFINISHED
83703-570 Enfortumab VedotinInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED
83703-571 Enfortumab VedotinInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED
83703-572 Choriogonadotropin AlfaInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED
83703-573 Rituximab-arrxInjection, SolutionDrug For Further ProcessingUNFINISHED
83703-574 Rituximab-arrxInjection, SolutionDrug For Further ProcessingUNFINISHED
83703-575 Rituximab-arrxInjection, SolutionDrug For Further ProcessingUNFINISHED
83703-576 Rituximab-arrxInjection, SolutionDrug For Further ProcessingUNFINISHED
83703-577 TemozolomideInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED
83703-578 Tisotumab VedotinInjection, Powder, For SolutionDrug For Further ProcessingUNFINISHED
83703-579 Tisotumab VedotinInjection, Powder, For SolutionDrug For Further ProcessingUNFINISHED
83703-580 Trastuzumab DeruxtecanInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED
83703-581 Rituximab-abbsInjection, Solution, ConcentrateDrug For Further ProcessingUNFINISHED
83703-582 Rituximab-abbsInjection, Solution, ConcentrateDrug For Further ProcessingUNFINISHED
83703-583 LurbinectedinInjection, Powder, Lyophilized, For SolutionDrug For Further ProcessingUNFINISHED